Kkr

The portfolio consists of road projects spanning 648 km across Andhra Pradesh and Gujarat. Macquarie is open to selling the portfolio as a whole or in three smaller packages, depending on buyer appetite

With KKR on board, Kerala’s Meitra Hospital to expand to other southern states, says founder Kottikollon

About 5% of Meitra’s revenue comes from overseas patients, largely from Oman. The share is expected to triple once additional capacity comes onstream, Faizal Kottikollon tells Moneycontrol

Rs 2 lakh crore worth of road assets up for monetisation in next 5 years, says Vertis Infra Trust CEO

InvITs have democratised infrastructure investing by offering Indian investors stable, inflation-hedged yields with strong governance, the KKR-backed roads InvIT CEO Gaurav Chandna tells Moneycontrol

KEF Holdings’ Meitra Hospital joins KKR’s healthcare platform in India

Founded by entrepreneur Faizal Kottikollon in 2012, Meitra Hospital is a JCI accredited, advanced quaternary care hospital of international standards located in Kozhikode

3 IPOs in pipeline, KKR’s Asia infra fund set for up to $700 million in exits

KKR has invested in roads and renewables through its Asia funds, deploying a significant portion of its collective $7 billion capital in India

InvIT IPOs gain momentum with deals worth over Rs 20,000 crore in the pipeline

India’s InvIT market has seen just four IPOs after the first such trust, IRB InvIT Fund, went public in 2017

‘My life, my game, my career’: After IPL failure, Venkatesh Iyer blocks out the naysayers

Despite being benched for a few IPL 2025 matches, Madhya Pradesh all-rounder Venkatesh Iyer maintains that the KKR management never lost faith in him.

Brookfield’s CleanMax, KKR-backed Hero Future Energies may file draft IPO papers by next week

Hero Future Energies is looking to raise around Rs 4,000 crore and CleanMax around Rs 5,000 crore

KKR may sell up to $300-million stake in Vertis Infrastructure Trust

KKR has a 71.66 percent stake followed by Ontario Teachers’ Pension Plan, which holds 24.99 percent in the roads infrastructure investment trust

KKR, Cube road InvITs plan IPO, may raise up to Rs 5,000 crore each

The move is aimed at tapping a wider pool of investors to meet growth capital requirements amid a rising demand for high-yield generating assets

India a 'standout investment destination' amid global volatility: KKR

KKR 2025 Mid-Year Global Macro Outlook report expects India's growth to remain resilient, supported by a strong domestic consumer market and structural reforms

KKR releases mid-year global macro outlook, urges investors to ‘make their own luck’ amid volatility

Rather than leaning into broad beta exposure, the firm recommends emphasising “control” in portfolios, whether through private equity investments with operational levers, or real assets offering inflation-linked cash flows

Macquarie prepares to sell its TOT road bundle for $1.5 billion

If the entire portfolio of nine roads is sold, it will be the biggest such deal in India, exceeding KKR’s acquisition of 13 roads from PNC Infratech for Rs 9,000 crore

Avendus sale faces delay as KKR, Gaja Capital squabble over exit premium

The deal, valued at approximately $700 million, will mark Mizuho's biggest investment in India, reflecting a major commitment to the Indian market

Torrent Pharma revives talks to acquire KKR’s stake in JB Pharma; deal expected soon

KKR’s stake is worth approximately Rs 13,400 crore considering the J B Pharma stock’s closing price of Rs 1,802.9 per share on June 27.

Cliffhanger sale of KKR - backed Avendus Capital: Carlyle back in fray as talks with Mizuho slow down

On February 20 , 2024, Moneycontrol was the first to report that KKR had revived the process to exit the leading home-grown firm.  Slowing down of discussions between Mizuho Financial Group and KKR backed Avendus Capital over "softer deal terms" do not necessarily mean that the Japanese group is out of the race, sources said.

KKR-backed InCred’s private credit arm to raise $174 million

The fund-raising underscores the growing need for capital in one of the world’s fastest-growing major economies

JB Chemicals Block Deal: Stock falls 7% as 90 lakh shares exchanged, KKR likely seller

Around 5.8 percent equity of JB Chemicals changed hands in a block deal, with KKR, the promoter of JB Chemicals and Pharmaceuticals, being the likely seller.

IPL 2025: Venkatesh Iyer unfazed by price tag pressure, focused on delivering for KKR

KKR's newly-appointed skipper Ajinkya Rahane seemed visibly irritated by the repeated discussions around Iyer's price tag and said he "deserved that price".

IPL: What Shah Rukh Khan thought on Gautam Gambhir's return to KKR in 2024

After a ten-year break, KKR won their third IPL title thanks in large part to Gambhir's return.

KKR remains unshaken and determined despite Gautam Gambhir's exit, says Head of Talent Scouting | Exclusive

IPL 2025: With KKR’s title defense on the horizon, the energy in the camp is palpable.

KKR acquires controlling stake in Healthcare Global Enterprises for $400 million

Founded in 1989, HCG is one of India’s largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs)

From power-hitter to all-round asset: Ramandeep Singh Prepares to bowl KKR to glory

As KKR prepares to kick off their IPL 2025 campaign against Royal Challengers Bengaluru at home on March 22, Ramandeep's evolution as a dual-threat player could prove crucial to the team's aspirations to retain the trophy.

KKR’s InvIT Highways Infrastructure Trust raises Rs 8,250 cr debt from Axis Bank, HDFC Bank, ICICI Bank, SBI

The funds will be utilized for meeting the financing needs for the acquisition of TOT Bundle 16 from the National Highway Authority of India (NHAI) and a portfolio of 12 road assets from PNC Infratech.

IPL 2025: Opening match set to feature KKR, RCB; final likely on May 25

The Royal Challengers Bangalore (RCB) have a new captain in Rajat Patidar, who replaced Faf du Plessis.